A 12-week intervention combining plant-derived protein with multi-strain probiotics delivered remarkable muscle preservation in 21-month-old rats, increasing grip strength by 55.96% and muscle mass indices by 23-28%. The treatment simultaneously reduced inflammatory markers TNF-α by 42% and IL-6 by 66%, while enhancing beneficial gut bacteria like Alistipes and boosting short-chain fatty acid production. This represents one of the most substantial muscle function improvements documented in aging research, suggesting the gut-muscle axis may be a more powerful therapeutic target than previously recognized. The mechanistic pathway—probiotics enhancing protein utilization through improved gut health and AMPK signaling—offers a compelling alternative to animal protein supplementation for sarcopenia prevention. However, translating these dramatic rodent results to humans remains uncertain, as aging processes and protein requirements differ significantly between species. The 56% strength improvement far exceeds typical human intervention outcomes, which rarely surpass 15-20%. Still, this work validates emerging theories that muscle aging isn't just about protein quantity but about optimizing the entire digestive-metabolic pathway that converts nutrients into functional muscle tissue.